06:20 EDT Nanobiotix jumps 56% to $7.85 after global licensing pact with Janssen
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NBTX:
- NBTX Soars On Teaming Up with Janssen for NBTXR3
- Nanobiotix announce global licensing pact with Johnson & Johnson for NBTXR3
- NANOBIOTIX Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3
- Voting Rights and Shares Capital of the Company
- NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update